Nexam Chemical Q4 net sales down 11% to SEK 43.2 million

Reuters
Jan 23
Nexam Chemical Q4 net sales down 11% to SEK 43.2 million

Nexam Chemical Holding AB reported its earnings for the fourth quarter (Q4) and full year (FY) 2025. For Q4 2025, net sales amounted to SEK 43.2 million, reflecting an 11% decrease. The gross margin for the quarter was 47%. The operating profit before depreciation (EBITDA) reached SEK 0.1 million. Cash and cash equivalents at the end of the quarter stood at SEK 12.2 million. Earnings per share before and after dilution were SEK -0.06 for the quarter. For the full year 2025, net sales totaled SEK 192.2 million. The gross margin for the year was 47%. Full-year EBITDA was SEK 3.4 million. Cash flow from operating activities amounted to SEK 11.3 million. Cash and cash equivalents at year-end were SEK 12.2 million. Earnings per share before and after dilution were SEK -0.19 for the year. The Board has proposed no dividend for 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexam Chemical Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 20260122:BIT:9786:0) on January 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10